|PTEN expression and KRAS mutations on primary tumors and metastases in the prediction of benefit from cetuximab plus irinotecan for patients with metastatic colorectal cancer|
F Loupakis, L Pollina, I Stasi, A Ruzzo, M Scartozzi, D Santini, G Masi, ...
Journal of clinical oncology 27 (16), 2622-2629, 2009
|MicroRNA expression and clinical outcomes in patients treated with adjuvant chemotherapy after complete resection of non–small cell lung carcinoma|
J Voortman, A Goto, J Mendiboure, JJ Sohn, AJ Schetter, M Saito, ...
Cancer research 70 (21), 8288-8298, 2010
|A specific missense mutation in GTF2I occurs at high frequency in thymic epithelial tumors|
I Petrini, PS Meltzer, IK Kim, M Lucchi, KS Park, G Fontanini, J Gao, ...
Nature genetics 46 (8), 844-849, 2014
|Thymic malignancies: from clinical management to targeted therapies|
RJ Kelly, I Petrini, A Rajan, Y Wang, G Giaccone
Journal of clinical oncology 29 (36), 4820, 2011
|PD-L1 mRNA expression in plasma-derived exosomes is associated with response to anti-PD-1 antibodies in melanoma and NSCLC|
M Del Re, R Marconcini, G Pasquini, E Rofi, C Vivaldi, F Bloise, ...
British journal of cancer 118 (6), 820-824, 2018
|Biology of MET: a double life between normal tissue repair and tumor progression|
Annals of translational medicine 3 (6), 2015
|Mutations of epigenetic regulatory genes are common in thymic carcinomas|
Y Wang, A Thomas, C Lau, A Rajan, Y Zhu, JK Killian, I Petrini, T Pham, ...
Scientific reports 4 (1), 1-11, 2014
|Contribution of KRAS mutations and c. 2369C> T (p. T790M) EGFR to acquired resistance to EGFR-TKIs in EGFR mutant NSCLC: a study on circulating tumor DNA|
M Del Re, M Tiseo, P Bordi, A D'Incecco, A Camerini, I Petrini, M Lucchesi, ...
Oncotarget 8 (8), 13611, 2017
|Phase II trial of sorafenib in combination with 5-fluorouracil infusion in advanced hepatocellular carcinoma|
I Petrini, M Lencioni, M Ricasoli, M Iannopollo, C Orlandini, F Oliveri, ...
Cancer chemotherapy and pharmacology 69 (3), 773-780, 2012
|Are MSCs angiogenic cells? New insights on human nestin-positive bone marrow-derived multipotent cells|
S Pacini, I Petrini
Frontiers in cell and developmental biology 2, 20, 2014
|Insulin‐like growth factor‐1 receptor and phosphorylated AKT‐serine 473 expression in 132 resected thymomas and thymic carcinomas|
PA Zucali, I Petrini, E Lorenzi, M Merino, L Cao, L Di Tommaso, HS Lee, ...
Cancer 116 (20), 4686-4695, 2010
|Copy number aberrations of BCL2 and CDKN2A/B identified by array-CGH in thymic epithelial tumors|
I Petrini, PS Meltzer, PA Zucali, J Luo, C Lee, A Santoro, HS Lee, ...
Cell death & disease 3 (7), e351-e351, 2012
|Expression and mutational status of c-kit in thymic epithelial tumors|
I Petrini, PA Zucali, HS Lee, MA Pineda, PS Meltzer, B Walter-Rodriguez, ...
Journal of Thoracic Oncology 5 (9), 1447-1453, 2010
|A multicenter phase II study of the combination of oxaliplatin, irinotecan and capecitabine in the first-line treatment of metastatic colorectal cancer|
E Vasile, G Masi, L Fornaro, S Cupini, F Loupakis, S Bursi, I Petrini, ...
British journal of cancer 100 (11), 1720-1724, 2009
|Lower airway inflammation before and after house dust mite nasal challenge: an age and allergen exposure-related phenomenon|
F Marcucci, G Passalacqua, GW Canonica, F Frati, S Salvatori, I Petrini, ...
Respiratory medicine 101 (7), 1600-1608, 2007
|The mitochondrial citrate carrier, SLC25A1, drives stemness and therapy resistance in non-small cell lung cancer|
HR Fernandez, SM Gadre, M Tan, GT Graham, R Mosaoa, MS Ongkeko, ...
Cell Death & Differentiation 25 (7), 1239-1258, 2018
|Evaluation of PTEN expression in colorectal cancer (CRC) metastases (mets) and in primary tumors as predictors of activity of cetuximab plus irinotecan treatment|
F Loupakis, L Pollina, I Stasi, G Masi, N Funel, M Scartozzi, I Petrini, ...
Journal of Clinical Oncology 26 (15_suppl), 4003-4003, 2008
|Loss of 18q22. 3 involving the carboxypeptidase of glutamate-like gene is associated with poor prognosis in resected pancreatic cancer|
JH Lee, E Giovannetti, JH Hwang, I Petrini, Q Wang, J Voortman, Y Wang, ...
Clinical Cancer Research 18 (2), 524-533, 2012
|Reproducibility of the WHO classification of thymomas: practical implications|
PA Zucali, L Di Tommaso, I Petrini, S Battista, HS Lee, M Merino, ...
Lung Cancer 79 (3), 236-241, 2013
|Mesenchymal cells inhibit expansion but not cytotoxicity exerted by gamma–delta T cells|
I Petrini, S Pacini, M Petrini, R Fazzi, L Trombi, S Galimberti
European journal of clinical investigation 39 (9), 813-818, 2009